Fred Hutchinson Cancer Research Center evolutionary biologist Dr. Harmit Malik has been elected a fellow of the American Association for the Advancement of Science, or AAAS. He is the 15th Fred Hutch scientist to be recognized by AAAS for their efforts to advance science or its applications. Malik, who is also a Howard Hughes Medical Institute Investigator, studies genetic conflict, in which evolutionary changes are…
Read More
The American Association for the Advancement of Science has named six faculty members from the University of Washington as AAAS Fellows, according to a Nov. 26 announcement. They are part of a cohort of 443 new fellows for 2019, all chosen by their peers for “scientifically or socially distinguished efforts to advance science or its applications.” The six UW faculty members…
Read More
Cancer immunotherapy expert Dr. Martin ‘Mac’ Cheever of Fred Hutchinson Cancer Research Center on Nov. 9 was awarded the first-ever Distinguished Service Award from the Society for the Immunotherapy of Cancer. The award honors Cheever’s work establishing and directing the Cancer Immunotherapy Trials Network. The federally funded network, often known by its acronym, CITN, conducts early-stage, multicenter clinical trials of promising immunotherapy agents…
Read More
The Puget Sound Business Journal honored pioneering virus researcher Dr. Denise Galloway of Fred Hutchinson Cancer Research Center on Thursday as a “Woman of Influence” at the news organization’s annual event to recognize noteworthy women of the regional business community. Galloway was one of 16 2019 Women of Influence feted at the Bellevue, Wash., ceremony. A panel of judges selected awardees from more than…
Read More
A team of researchers from Fred Hutchinson Cancer Research Center and its partner institutions, University of Washington and Seattle Cancer Care Alliance, just received a coveted Department of Defense Breast Cancer Research Program Breakthrough award. The four-year, $4 million award, led by principal investigators Drs. Cyrus Ghajar and Stanley Riddell of Fred Hutch, will launch an innovative investigation aimed at preventing late-onset, metastatic breast…
Read More
In pursuit of changing the course of Alzheimer’s, support is growing to explore new avenues that might unlock mysteries of this brain disease. This includes investigating the link between aging eyes and aging brains. Cecilia Lee, an assistant professor of ophthalmology at the University of Washington School of Medicine, recently received a $17.2 million grant from the National Institute on…
Read More
Ashleigh Theberge, a University of Washington assistant professor of chemistry, has been named a 2019 Packard Fellow for her research on cell signaling. Every year since 1988, the David and Lucile Packard Foundation has awarded Packard Fellowships in Science and Engineering to early-career scientists to pursue the types of innovative projects that often fall outside the purview of traditional sources of funding, such as…
Read More
Fred Hutchinson Cancer Research Center’s Dr. M. Elizabeth ‘Betz’ Halloran has been elected to the National Academy of Medicine, a high honor in the fields of health and medicine. Halloran is one of the world’s top experts in statistical methods for evaluating vaccines and vaccination strategies to stop outbreaks of deadly infectious diseases. The Academy announced its 100 new members today in conjunction with its annual…
Read More
Dr. Michael Boeckh, one of the world’s leading experts in viruses that afflict patients with compromised immune systems, will deliver the prestigious John F. Enders Lecture Oct. 5 in Washington, D.C., at IDWeek, an annual conference of doctors and researchers specializing in infectious diseases. Boeckh is head of the Infectious Disease Sciences program at Seattle’s Fred Hutchinson Cancer Research Center. He will talk…
Read More
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $30 million in first-year funding to establish new centers for immunology research to accelerate progress in tuberculosis (TB) vaccine development. New and improved TB vaccines are badly needed. Over the past 200 years, TB has claimed the lives of more than 1 billion people—more…
Read More